Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...
The Board of Directors at their meeting held on 6th May, 2025 has recommended Dividend of H11/- (550%) per equity share having face value of H2/- each for the financial year 2024-25 which is the same ...
Choosing between multiple stocks can be challenging -- especially when they belong to different sectors. Moneycontrol’s Compare Stocks tool makes this easier by letting you analyse up to three ...
The Elder Scrolls 4: Oblivion is a vast open world that’s easy to get lost in as you begin your adventures across the realm of Cyrodiil. With 9 major cities, several guilds, and countless quests to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results